Schedule 13D ownership disclosure
Biopharmx
Security class unavailable · CUSIP: 09072X101
Event date: 2016-08-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000038777-16-000569
- Form type
- SC 13D
- Filer
- BioPharmX Corp
- CIK
- CIK 1504167
- Filed
- Aug 26, 2016
- Reporting period
- Aug 17, 2016
- Description
- Schedule 13D beneficial ownership